CAPR News

Capricor Therapeutics Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Capricor Therapeutics, Inc. - CAPR

CAPR DEADLINE: ROSEN, TOP-RANKED INVESTOR COUNSEL, Encourages Capricor Therapeutics, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - CAPR

Investor Alert: Deadline Approaching to Join Capricor Therapeutics, Inc. (CAPR) Class Action - Contact Levi & Korsinsky

Pomerantz LLP Notifies Investors of Class Action Against Capricor Therapeutics, Inc. – CAPR

Lost Money on Capricor Therapeutics, Inc. (CAPR)? Join Class Action Before September 28, 2026 - Contact Levi & Korsinsky

Hagens Berman Alerts Capricor Therapeutics, Inc. (NASDAQ: CAPR) Investors to FDA Review Extension for Deramiocel Amid Ongoing Securities Class Action and September 28 Lead Plaintiff Deadline

CAPR INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Reminds Capricor Investors of Securities Class Action Lawsuit Deadline on September 28, 2026 Ready to Announce with Confidence?

Kaplan Fox Alerts Capricor Therapeutics, Inc. (CAPR) Investors to the Lead Plaintiff Deadline on September 28, 2026 Ready to Announce with Confidence?

Class Action Lawsuit Filed: Capricor Therapeutics, Inc. (CAPR) - Join by September 28, 2026 - Contact Levi & Korsinsky

CAPR INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Capricor Therapeutics, Inc. Stockholders Have Opportunity to Lead Class Action Lawsuit!